PHARMACEUTICAL COMPOSITION HAVING CEREBRAL CELL PROTECTING ACTION

PURPOSE:To obtain a pharmaceutical composition having selective cerebral cell protecting action, by using a specific piperazine derivative as an active component. CONSTITUTION:A compound of formula (R is H or lower alkyl; R is OH, aralkyloxy, 1-5C alkoxy or 3-5C alkenyloxy; R is H, aralkyloxy, 1-5C...

Full description

Saved in:
Bibliographic Details
Main Authors KOGURE HISAYA, MAZAKI MITSUO
Format Patent
LanguageEnglish
Published 04.03.1988
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PURPOSE:To obtain a pharmaceutical composition having selective cerebral cell protecting action, by using a specific piperazine derivative as an active component. CONSTITUTION:A compound of formula (R is H or lower alkyl; R is OH, aralkyloxy, 1-5C alkoxy or 3-5C alkenyloxy; R is H, aralkyloxy, 1-5C alkoxy or 3-5C alkenyloxy; R is H or 1-5C alkoxy) [e.g. 1-(3,4- dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl)etha-nol] is used as an active component of the present composition. The compound is administered usually at a rate of 0.5-100mg/day for injection and 5-1,000mg/day for oral administration for adults.
Bibliography:Application Number: JP19860194925